Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01988038

Repository Study of Autosomal Dominant Polycystic Kidney Disease

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
The Rogosin Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The design and establishment of the Polycystic Kidney Disease (PKD) Data Repository does not require, and may be constrained by, a narrowly conceived hypothesis. However, the PKD Repository has been designed to include demographic, clinical, biochemical, and genetic data that will further explore the natural history of the disorder and assess the factors that are likely to be associated with the progression of disease and the incidence of complications including renal failure, cardiovascular disease, and stroke.

Detailed description

The goal of this project is to collect data from a large population of patients with PKD. Based upon the estimated prevalence of PKD (1:500 and 1:1000 live births), it is estimated that there may be 10,000 PKD patients in the New York City area. This sample size far exceeds any database established thus far. As many as 40% of affected PKD patients are reportedly unaware of a family history of this disease, in part because many patients may go undiagnosed until they present with a medical complication (e.g., hypertension, kidney failure). Furthermore, this initiative will provide an opportunity to compare data from racially diverse populations.

Conditions

Timeline

Start date
2013-11-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2013-11-20
Last updated
2017-03-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01988038. Inclusion in this directory is not an endorsement.